Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-412 | |
Phytochemical name or plant extracts | Salvia syriaca extract | |
PMID | 24082637 | |
Literature evidence | These could be considered as a potential source for novel anticancer therapy. | |
IUPAC name | NA | |
Phytochemicals’ class or type of plant extracts | Ethanolic extract | |
Source of phytochemicals or plant Extracts | Salvia syriaca | |
Geographical availability | Iran, Iraq, Lebanon-Syria, Palestine, Transcaucasus, Turkey | |
Plant parts | NA | |
Other cancers | Breast cancer | |
Target gene or protein | NA | |
Gene or Protein evidence | NA | |
Target pathways | NA | |
IC50 | 24.09 ± 5.058 μg/ml against MCF-7 30.13 ± 3.09 μg/ml against T47D 23.93 ± 12.51 μg/ml against BT-474 52.08 ± 7.88 μg/ml against ZR-75-1 | |
Potency | NA | |
Cell line/ mice model | MCF-7, T47D, ZR-75-1, BT-474 | |
Additional information | NA | |
PubChem ID | NA | |
Additional PMIDs | NA | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:457350-1 | |
Safety | NA |